Dolby Laboratories, Inc. (DLB) Stock: Price, Forecast & Analyst Target
Dolby Laboratories, Inc. (DLB) — MoonshotScore 84/100 (Exceptional band), calculated Nov 18, 2026. Price $54.77 (-3.52%), as of the Nov 19, 2026 trading session; market cap $5.13B. Expected results Feb 4, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Dolby Laboratories, Inc. · DLB · NYSE · Technology · Software - Application
Research dated 2026-09-13: Dolby makes codec and technology licenses for media playback—its Atmos, Vision, and audio codec standards power everything from cinema to streaming to mobile. Revenue collapsed between consecutive reporting periods, raising the question whether this is a temporary dip tied to specific customer cycles or the start of a structural shrinking in licensing demand.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Dolby Laboratories (DLB)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and a fortress balance sheet, though growth is only middling; the market is already moving on it. Business Quality: Elite; Financial Safety: Fortress; Valuation: Fair; Growth Durability: Flat; Momentum: Rising.
- EPS beat 8 of the last 8 reports
- Altman Z 8.24 · Piotroski F 7
- ROE 8.7% · ROA 7.2% · current ratio 3.19 · earnings yield 3.8% · free-cash-flow yield 5.8%
Helping: business quality, balance-sheet strength, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 83 | Exceptional | |
| 83 | Exceptional | |
| 82 | Exceptional | |
| 82 | Exceptional | |
| 84 | Exceptional | |
| 84 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $54.77 | |
| Change on the day | -3.52% | |
| 52-week range | $48.26–$69.95 | |
| Market capitalisation | $5.13B | — |
| Price / earnings (trailing) | 21.55 | |
| Shares traded on the day | 2.19M | |
| Beta (volatility vs the S&P 500) | 0.78 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Estimated dates can change.
Other perspectives
Council score for Dolby Laboratories (DLB): perspectives
Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.
5-Factor Breakdown
Legends Council
5 lenses, 5 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
Two of these lenses read this company less favourably than the MoonshotScore does: Griffin-style lens and Englander-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.
On Nov 18, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Dolby Laboratories (DLB), and what does it report?
Short answer · as of
Dolby is fundamentally a licensing business.
Research dated 2026-09-13.
It doesn't make the end products—studios, device makers, and broadcasters license its codec and audio/visual standards to encode and decode media. The company also manufactures cinema equipment (servers, processors, speakers) and provides post-production services, but licensing is the core.
Reported results show segment revenue for licensing across Consumer Electronics, Personal Computers, Mobile, Other, and Broadcast—each a different royalty pool. The recent quarter shows a sharp dip in reported revenue, which at first glance looks like a cliff, until you recognize this business has lumpy demand tied to content production cycles and device refresh waves.
What do the latest results show for Dolby Laboratories (DLB)?
Research dated 2026-09-13.
The most recent quarter revenue fell steeply from the prior reporting period, with the decline becoming more pronounced in net profit, implying either a temporary cost burden or underlying margin pressure. Management has guided for the full fiscal year revenue broadly in line with prior-year levels, suggesting they see the recent dip as temporary.
Licensing revenue in particular is expected to stabilize ahead in the forthcoming guidance period. The sharp near-term decline alongside full-year guidance that implies recovery creates the central tension: is demand cycling back, or are the recent weeks a sign of something more lasting?
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $0.00 Jun 30, 2026
- Latest quarter · SG&A
- $0.00 Jun 30, 2026
- Latest quarter · FMP standardized operating result
- $0.00 Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $0.00 | Not available | $0.00 | $0.00 |
| Jan 21, 1970 | $0.00 | Not available | $0.00 | $0.00 |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $373.54M Nov 17, 2026
- Latest report · revenue estimate
- $372.76M Nov 17, 2026
- Latest report · revenue vs estimate
- Above estimate Nov 17, 2026
- Latest report · EPS vs estimate
- Above estimate Nov 17, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Nov 17, 2026 | $373.54M | $372.76M | $1.2500 | $1.2000 |
| Jul 30, 2026 | $305.00M | $311.96M | $0.6900 | $0.6710 |
| Apr 30, 2026 | $395.63M | $385.80M | $1.3700 | $1.3100 |
| Jan 29, 2026 | $346.71M | $341.26M | $1.0600 | $0.9930 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Jun 2025 | $316M | $46M | $0.48 (diluted) |
| Q4 FY2025 | $307M | $49M | $0.51 (diluted) |
| Q1 FY2026 | $347M | $53M | $0.55 (diluted) |
| Q2 FY2026 | $396M | $95M | $0.99 (diluted) |
What are the financial strengths and risks for Dolby Laboratories (DLB)?
Short answer · as of
Cash and short-term investments were $0.00 at the Jun 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-13.
Cash covers total debt many times over, and the cash balance has substantial room to handle extended periods with depressed cash inflow. The company's gross margin, historically above most software firms, stands at a level suggesting the core licensing economics remain intact even if reporting-period volumes wobble.
Operating margin has compressed in recent periods—a sign that fixed costs in research and marketing are harder to cover in a lower-volume period. The balance sheet shows minimal financial risk, but the real exposure is to changes in how media is consumed and encoded globally; if a newer codec standard displaced Dolby's intellectual property, or if streaming device makers shifted licensing strategies, the recurring revenue model would face existential pressure.
What should you watch next at Dolby Laboratories (DLB)?
Short answer · as of
The next earnings report is expected on Feb 4, 2027.
Research dated 2026-09-13.
Watch whether the guidance for the coming reporting period is met—it will show whether management's recovery view is correct or optimistic. The next earnings call will detail which customer segments drove the decline and whether they expect to return.
Insider transactions show officers have been selling, not buying, in recent months—a sign worth monitoring, though forms describe transactions, not always motives. Watch also for any announcements about new Dolby technologies or customer wins; the codec and standard-licensing game often hinges on whether new platforms and device types adopt the technology early.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does Dolby Laboratories compare with its peers?
Short answer
Dolby Laboratories's score ranks 8th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Dolby is one of few stand-alone codec and media-standard licensors; most competitors are embedded inside semiconductor firms or device makers. Its advantage is focus—the entire company optimizes around licensing and servicing those standards.
Its disadvantage is concentration: device makers can't easily drop Dolby without fragmenting playback, but they can negotiate harder when licensing costs are material to a margin-critical hardware business. Unlike competitors that bundle codecs into broader platforms, Dolby sells a service—the assurance that media encoded to its standard plays on any licensee's device.
That focus is also its greatest vulnerability: if the industry standardizes around open or lower-cost encoding, Dolby's premium-pricing moat erodes overnight.
| Company | Price | Market value | Score |
|---|---|---|---|
| $116.80 Nov 18, 2026 | $5.82B | 92 5-pillar Nov 18, 2026 | |
| $67.23 Nov 19, 2026 | $5.67B | 91 5-pillar Nov 18, 2026 | |
| $20.30 Nov 18, 2026 | $3.59B | 91 5-pillar Nov 18, 2026 | |
| $15.52 Nov 18, 2026 | $7.34B | 88 5-pillar Nov 18, 2026 | |
| $67.23 Nov 19, 2026 | $4.15B | 87 5-pillar Nov 18, 2026 | |
| $89.85 Nov 18, 2026 | $5.15B | 86 5-pillar Nov 18, 2026 | |
| $28.07 Nov 19, 2026 | $4.59B | 86 5-pillar Nov 18, 2026 | |
| Dolby Laboratories (DLB) — this page | $54.77 | $5.13B | 84 |
| $150.95 Nov 18, 2026 | $6.18B | 82 5-pillar Nov 18, 2026 | |
| $149.38 Nov 19, 2026 | $7.05B | 79 5-pillar Nov 18, 2026 | |
| $276.58 Nov 18, 2026 | $7.12B | 77 5-pillar Nov 18, 2026 | |
| $41.98 Nov 18, 2026 | $7.02B | 76 5-pillar Nov 18, 2026 | |
| $66.43 Nov 18, 2026 | $3.62B | 72 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $85.00 – $85.00
- Consensus target
- $85.00
- Median target
- $85.00
Consensus record · Captured .
Measured against a quoted price of $54.77 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Oct 2, 2026
- Transactions
- 29
- Identified insiders
- 6
- Purchases
- 0
- Sales
- 10
- Other transactions
- 19
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held DLB in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported DLB in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Dolby Laboratories (DLB)?
DLB Technology Stock FAQ
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
Why does Dolby Atmos matter if most people cannot distinguish it from standard surround sound?
Atmos drives licensing fees upstream in the production and playback chain. Streaming services license Atmos to signal premium tier differentiation; cinema operators license it as a draw for theatrical experience. The market-level adoption matters more than individual perception—studios will pay to encode in Atmos if enough viewing platforms support it, and device makers will license it if enough content demands it. The cycling question for investors is whether this adoption curve is still expanding or has begun to mature.
Does Dolby charge per device sold, or do device makers pay a flat license fee?
The company structures licensing revenue across segments: mobile, personal computers, consumer electronics, broadcast, and other. Each segment likely has its own pricing model—mobile is typically a per-unit royalty given the volume, whereas broadcast equipment may carry larger upfront fees. Management guidance calls out licensing revenue separately from service and product revenue, indicating it comes from multiple contract types. The segment data shows where that revenue clusters, but the invoice mechanics vary by customer and use case.
Could Dolby's codec licensing moat be disrupted by an open-source alternative?
Open codecs exist and are adopted in some contexts, but Dolby's advantage is the ecosystem—device makers, studios, and platforms have already licensed and integrated its standards. A new standard would need to offer dramatically better quality or cost to justify the switching cost. That said, technology evolution is relentless; if a superior encoding method emerged and was adopted by a critical mass of platforms, Dolby would face pricing pressure or license resistance. The company's ability to stay ahead in innovation and maintain customer switching costs is the core competitive moat.
Why are insiders selling Dolby stock heavily despite management's full-year guidance?
Recent insider transactions show net selling over recent months, though the filings themselves do not disclose intent—sales could be routine vesting, tax-loss harvesting, or rebalancing. The heavy selling does not necessarily signal management doubt about the full-year outlook; it could reflect that officers' compensation packages have created concentrated holdings they wish to diversify. However, the pattern is worth watching alongside results ahead: if insiders continue selling while revenue stabilizes, it could mean management's public optimism differs from private conviction about longer-term growth.
What is the DLB stock price today?
The last price recorded for Dolby Laboratories, Inc. (DLB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the DLB price target?
The analyst consensus price target for Dolby Laboratories, Inc. (DLB), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Claude (claude-haiku-4-5) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 49 figures on this page — 1 from SEC filings and earnings calls, 41 from Financial Modeling Prep (FMP), 4 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com